GlaxoSmithKline (GSK): Health Outcomes - Esprit R&D Leadership Development Programme

Health Outcomes - Esprit R&D Leadership Development Programme

Are you a Health Outcomes scientist with experience gained in a pharmaceutical, biotech or academic environment eager to become an outstanding leader? An inquisitive mind who would thrive on a diverse, intellectually demanding global leadership programme? Do you want to translate your health outcomes expertise into disease-beating medicines? And help people across the world to do more, feel better and live longer?

We are a science-led, global healthcare company that puts patients first. Our business is focused on developing medicines that improve the quality of human life. To meet the future strategic challenges this entails, we need to fast-track the finest health outcomes talent into senior leadership roles within our business.

Esprit R&D is an initial three-year, accelerated, multi-disciplinary and individually tailored programme. It is heavily backed by our senior management team, and it will give you incredible standing among your peers.

Over the three years, you’ll undertake high-profile, global rotations that will give you a breadth of experiences across global, regional and market-facing roles and it is anticipated that you will transition into a leadership role within a key functional area upon successfully completing this programme. You’ll apply this knowledge across a range of drug development disciplines from discovery research to commercialisation and business development. And as well as learning from thought leaders in your field, you’ll benefit from unrivalled formal training, mentoring, coaching and development to enhance your leadership capabilities.

To be eligible for our Esprit R&D programme, you’ll need:

• A degree with further qualifications in health outcomes.

• Broad experience in health economics/outcomes research including marketed and/or pipeline products gained in a highly credible organisation and ideally some experience gained in the pharmaceutical, biotech or academic field, plus excellent theoretical and practical skills.

• Strategic decision-making skills, ideally in a global commercial environment.

• Innovation, creativity and the ability to solve complex problems.

• The ability to adapt and learn new areas while working as part of a team.

•The insight and curiosity to challenge traditional boundaries and creatively integrate health outcomes applications into the context of early discovery, clinical development, comparative effectiveness and health policy discussions.  

• Global mobility for one 12-month assignment.

Opportunities are available in both the UK and US and will be open for applications from 1st July to 17th July 2013.  To find out more and apply, please visit www.gsk.com/esprit where you will be able to gain more insight and review an FAQ fact sheet.  

Please note that a final assessment centre will be held on 22nd and 23rd October 2013 in London, UK.

GlaxoSmithKline (GSK) is a place where ideas come to life.

Comments

Post a Comment

Popular posts from this blog

Protein folding via charge zippers

Jan. 18, 2013 — Membrane proteins are the "molecular machines" in biological cell envelopes. They control diverse processes, such as the transport of molecules across the lipid membrane, signal transduction, and photosynthesis. Their shape, i.e. folding of the molecules, plays a decisive role in the formation of, e.g., pores in the cell membrane. In the journal Cell, researchers of Karlsruhe Institute of Technology and the University of Cagliari are now reporting a novel charge zipper principle used by proteins to form functional units. "It is fascinating to see the elegant basic principles that are used by nature to construct molecular assemblies," explains Anne Ulrich, Director of the KIT Institute for Biological Interfaces. "A charge zipper between the charged side chains is an entirely unexpected mechanism used by membrane proteins to neutralize their charges such that they can be immersed into hydrophobic cell membranes....
Read more

Lonza: CMC Product Manager

Due to the expansion of Lonza's Analytical Services department we are looking to recruit an Analytical Product Manager. Reporting to the Group Leader you will proactively coordinate internal and external client project activities (analytical CMC development of recombinant proteins) performed within Analytical Services and to provide scientific oversight of data generated for the projects. Responsibilities:      * Primary point of contact for all analytical activities relating to product development and management of analytical development programmes from early phase development through to license application.      * Primary interface to the Program Management Team, AS study directors and internal and external customers.      * Definition, presentation and representation of analytical CMC programmes to customers, potential new customers & external meetings, including oversight of large analytical portfolio projects.      * Design an...
Read more

GlaxoSmithKline (GSK): Esprit Physician Leadership Development Programme

Esprit Physician Leadership Development Programme Are you an MBBS or MD with experience gained in a pharmaceutical, biotech or academic environment eager to become an outstanding leader? An inquisitive mind who would thrive on a diverse, intellectually demanding global leadership programme? Do you want to translate your medical expertise into disease-beating medicines? And help people across the world to do more, feel better and live longer? We are a science-led, global healthcare company that puts patients first. Our business is focused on developing medicines that improve the quality of human life. To meet the future strategic challenges this entails, we need to fast-track the finest medical talent into senior leadership roles within our business. The Esprit Physician programme is an initial three-year, accelerated, multi-disciplinary and individually tailored programme. It is heavily backed by our senior management team, and it will give you incredible standing as a phys...
Read more